• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[外周动脉闭塞性疾病作为高动脉粥样硬化负荷的预测指标]

[Peripheral arterial occlusive disease as predictor of high atherosclerotic burden].

作者信息

Espinola-Klein C, Vosseler M, Abegunewardene N, Himmrich L, Schlosser A, Schuster C-J

机构信息

Zentrum für Kardiologie/Kardiologie I, Universitätsmedizin der Johannes-Gutenberg-Universität, Langenbeckstr. 1, 55131, Mainz, Deutschland.

Gefäßzentrum/Angiologie, Helios Klinikum Erfurt, Erfurt, Deutschland.

出版信息

Herz. 2019 Feb;44(1):40-44. doi: 10.1007/s00059-018-4774-3.

DOI:10.1007/s00059-018-4774-3
PMID:30627741
Abstract

Atherosclerosis is a disease which affects the whole arterial vascular tree. In particular patients with peripheral arterial occlusive disease (PAOD) often suffer from additional atherosclerotic manifestations in other vascular territories. This has a direct impact on cardiovascular prognosis. Atherosclerosis is an inflammatory disease. A high inflammatory burden is associated with polyvascular atherosclerosis and also with the occurrence of cardiovascular events. Control of cardiovascular risk factors is crucial for the treatment of patients with polyvascular atherosclerosis. In addition, anticoagulation treatment is very important in patients with atherosclerosis. Moreover, exercise training is an important treatment option in PAOD patients not only to improve walking distance but also for multiple additional positive effects. So far the role of anti-inflammatory treatment is not clear and must be further elaborated by future clinical research.

摘要

动脉粥样硬化是一种影响整个动脉血管系统的疾病。特别是患有外周动脉闭塞性疾病(PAOD)的患者,常常在其他血管区域出现额外的动脉粥样硬化表现。这对心血管预后有直接影响。动脉粥样硬化是一种炎症性疾病。高炎症负荷与多血管动脉粥样硬化以及心血管事件的发生有关。控制心血管危险因素对于多血管动脉粥样硬化患者的治疗至关重要。此外,抗凝治疗在动脉粥样硬化患者中非常重要。而且,运动训练对于PAOD患者是一种重要的治疗选择,不仅可以改善步行距离,还具有多种其他积极作用。到目前为止,抗炎治疗的作用尚不清楚,必须通过未来的临床研究进一步阐明。

相似文献

1
[Peripheral arterial occlusive disease as predictor of high atherosclerotic burden].[外周动脉闭塞性疾病作为高动脉粥样硬化负荷的预测指标]
Herz. 2019 Feb;44(1):40-44. doi: 10.1007/s00059-018-4774-3.
2
Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.多血管动脉粥样硬化疾病:认识风险并管理该综合征。
Curr Med Res Opin. 2009 Nov;25(11):2631-41. doi: 10.1185/03007990903223895.
3
Medical treatment of peripheral artery occlusive disease (PAOD).外周动脉闭塞性疾病(PAOD)的医学治疗。
Acta Chir Belg. 2000 Sep-Oct;100(5):190-3.
4
[Manifestations of atherosclerosis in various vascular regions. Similarities and differences regarding epidemiology, etiology and prognosis].[不同血管区域动脉粥样硬化的表现。关于流行病学、病因学和预后的异同]
Med Klin (Munich). 2002 Apr 15;97(4):221-8. doi: 10.1007/s00063-002-1144-x.
5
Predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease.外周动脉闭塞性疾病中中性粒细胞与淋巴细胞比值升高对长期心血管死亡率的预测价值
J Cardiol. 2014 Nov;64(5):371-6. doi: 10.1016/j.jjcc.2014.02.019. Epub 2014 Mar 28.
6
Repetitive application of remote ischemic conditioning (RIC) in patients with peripheral arterial occlusive disease (PAOD) as a non-invasive treatment option: study protocol for a randomised controlled clinical trial.重复应用远程缺血预处理(RIC)作为一种非侵入性治疗选择治疗外周动脉闭塞性疾病(PAOD)患者:一项随机对照临床试验的研究方案。
BMC Cardiovasc Disord. 2022 Aug 4;22(1):353. doi: 10.1186/s12872-022-02795-3.
7
How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology.如何管理患有多血管动脉粥样硬化疾病的患者。血管病国际联盟立场文件。
Int Angiol. 2021 Feb;40(1):29-41. doi: 10.23736/S0392-9590.20.04518-6. Epub 2020 Sep 7.
8
[Role of lipid lowering therapy in patients with peripheral arterial occlusive disease].[降脂治疗在周围动脉闭塞性疾病患者中的作用]
Herz. 2004 Feb;29(1):12-6. doi: 10.1007/s00059-004-2542-z.
9
Interrelationship between peripheral arterial occlusive disease, carotid atherosclerosis and flow mediated dilation of the brachial artery.外周动脉闭塞性疾病、颈动脉粥样硬化与肱动脉血流介导的扩张之间的相互关系。
Int Angiol. 2003 Mar;22(1):83-7.
10
The Association of Periodontitis and Peripheral Arterial Occlusive Disease-A Systematic Review.牙周炎与外周动脉阻塞性疾病相关性的系统评价。
Int J Mol Sci. 2019 Jun 15;20(12):2936. doi: 10.3390/ijms20122936.

引用本文的文献

1
Changes in miRNA expression in patients with peripheral arterial vascular disease during moderate- and vigorous-intensity physical activity.外周动脉血管疾病患者在中等和剧烈强度体力活动期间 miRNA 表达的变化。
Eur J Appl Physiol. 2023 Mar;123(3):645-654. doi: 10.1007/s00421-022-05091-2. Epub 2022 Nov 23.
2
[Principles of angiology in lower extremity arterial disease (LEAD)].[下肢动脉疾病(LEAD)的血管病学原理]
Herz. 2020 Apr;45(2):201-208. doi: 10.1007/s00059-020-04896-1.

本文引用的文献

1
[Peripheral Arterial Disease: When is a PCSK9 Inhibitor Useful?].[外周动脉疾病:前蛋白转化酶枯草溶菌素9抑制剂何时有用?]
Dtsch Med Wochenschr. 2018 Sep;143(19):1391-1396. doi: 10.1055/a-0639-8325. Epub 2018 Jul 4.
2
Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease.他汀类药物剂量与外周动脉疾病患者截肢和生存的关系。
Circulation. 2018 Apr 3;137(14):1435-1446. doi: 10.1161/CIRCULATIONAHA.117.032361. Epub 2018 Jan 12.
3
[ESC guidelines 2017 on peripheral arterial diseases : Summary of the most important recommendations and innovations].
[2017年欧洲心脏病学会外周动脉疾病指南:最重要建议及创新要点总结]
Herz. 2017 Dec;42(8):721-727. doi: 10.1007/s00059-017-4638-2.
4
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).依洛尤单抗降低低密度脂蛋白胆固醇水平及外周动脉疾病患者的结局:来自 FOURIER 试验(在高风险人群中用 PCSK9 抑制剂进行进一步心血管结局研究)的见解。
Circulation. 2018 Jan 23;137(4):338-350. doi: 10.1161/CIRCULATIONAHA.117.032235. Epub 2017 Nov 13.
5
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.利伐沙班联合或不联合阿司匹林治疗稳定的外周动脉或颈动脉疾病患者:一项国际、随机、双盲、安慰剂对照试验。
Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.
6
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
7
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
8
[Vascular diagnostics in peripheral arteries].[外周动脉的血管诊断]
Internist (Berl). 2017 Aug;58(8):787-795. doi: 10.1007/s00108-017-0272-6.
9
Supervised exercise training in peripheral arterial disease increases vascular shear stress and profunda femoral artery diameter.外周动脉疾病的监督性运动训练可增加血管切应力和股深动脉直径。
Eur J Prev Cardiol. 2017 Jan;24(2):178-191. doi: 10.1177/2047487316665231. Epub 2016 Sep 27.
10
Influence of exercise training on proangiogenic TIE-2 monocytes and circulating angiogenic cells in patients with peripheral arterial disease.运动训练对周围动脉疾病患者促血管生成性TIE-2单核细胞和循环血管生成细胞的影响。
Clin Res Cardiol. 2016 Aug;105(8):666-676. doi: 10.1007/s00392-016-0966-0. Epub 2016 Jan 30.